This company has been marked as potentially delisted and may not be actively trading. Neurotrope (NTRP) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsShort InterestTrendsBuy This Stock NTRP vs. MOND, BKNG, EXPE, XPO, MMYT, GATX, GXO, VRRM, GBTG, and HAFNShould you be buying Neurotrope stock or one of its competitors? The main competitors of Neurotrope include Mondee (MOND), Booking (BKNG), Expedia Group (EXPE), XPO (XPO), MakeMyTrip (MMYT), GATX (GATX), GXO Logistics (GXO), Verra Mobility (VRRM), Global Business Travel Group (GBTG), and Hafnia (HAFN). These companies are all part of the "transportation services" industry. Neurotrope vs. Its Competitors Mondee Booking Expedia Group XPO MakeMyTrip GATX GXO Logistics Verra Mobility Global Business Travel Group Hafnia Mondee (NASDAQ:MOND) and Neurotrope (NASDAQ:NTRP) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership, community ranking and analyst recommendations. Does the media favor MOND or NTRP? In the previous week, Neurotrope had 1 more articles in the media than Mondee. MarketBeat recorded 1 mentions for Neurotrope and 0 mentions for Mondee. Mondee's average media sentiment score of 0.00 equaled Neurotrope'saverage media sentiment score. Company Overall Sentiment Mondee Neutral Neurotrope Neutral Which has higher valuation and earnings, MOND or NTRP? Neurotrope has lower revenue, but higher earnings than Mondee. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMondee$232.97M0.00-$60.82M-$1.16N/ANeurotrope$630K9.34N/AN/AN/A Does the MarketBeat Community believe in MOND or NTRP? Neurotrope received 165 more outperform votes than Mondee when rated by MarketBeat users. However, 83.33% of users gave Mondee an outperform vote while only 62.94% of users gave Neurotrope an outperform vote. CompanyUnderperformOutperformMondeeOutperform Votes1583.33% Underperform Votes316.67%NeurotropeOutperform Votes18062.94% Underperform Votes10637.06% Do insiders and institutionals hold more shares of MOND or NTRP? 32.1% of Mondee shares are owned by institutional investors. Comparatively, 3.8% of Neurotrope shares are owned by institutional investors. 46.1% of Mondee shares are owned by company insiders. Comparatively, 8.4% of Neurotrope shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk and volatility, MOND or NTRP? Mondee has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, Neurotrope has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500. Do analysts rate MOND or NTRP? Mondee currently has a consensus target price of $3.63, suggesting a potential upside of 0.00%. Neurotrope has a consensus target price of $5.00, suggesting a potential upside of 35.13%. Given Neurotrope's higher probable upside, analysts clearly believe Neurotrope is more favorable than Mondee.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mondee 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Neurotrope 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is MOND or NTRP more profitable? Neurotrope has a net margin of 0.00% compared to Mondee's net margin of -33.46%. Mondee's return on equity of 0.00% beat Neurotrope's return on equity.Company Net Margins Return on Equity Return on Assets Mondee-33.46% N/A -20.56% Neurotrope N/A -806.36%-112.57% SummaryMondee beats Neurotrope on 8 of the 13 factors compared between the two stocks. Get Neurotrope News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NTRP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRP vs. The Competition Export to ExcelMetricNeurotropeTransportation services IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$5.88M$13.03B$7.98B$8.62BDividend YieldN/A3.58%3.19%4.17%P/E RatioN/A16.0315.1319.96Price / Sales9.343.133.73157.63Price / CashN/A25.8516.3734.64Price / Book1.113.504.824.69Net IncomeN/A$467.60M$257.95M$248.14M Neurotrope Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRPNeurotrope1.4145 of 5 stars$3.70-2.1%$5.00+35.1%+94.8%$5.88M$630K0.005Gap DownMONDMondeeN/AN/A$3.63+∞N/A$87K$232.97M0.001,226BKNGBooking4.1024 of 5 stars$5,539.41-1.3%$5,388.37-2.7%+40.9%$180.25B$24.09B32.0124,300Positive NewsAnalyst RevisionEXPEExpedia Group4.4164 of 5 stars$176.62+0.0%$186.35+5.5%+37.8%$22.45B$13.79B19.5216,500Positive NewsShort Interest ↑XPOXPO4.2568 of 5 stars$119.61+1.0%$134.63+12.6%+14.6%$13.96B$8.01B37.0323,000Analyst ForecastMMYTMakeMyTrip3.9097 of 5 stars$99.69-0.8%$127.50+27.9%+27.6%$10.94B$978.34M54.183,340Positive NewsGATXGATX1.6166 of 5 stars$157.14+0.1%$167.67+6.7%+17.0%$5.61B$1.63B20.221,900GXOGXO Logistics1.8726 of 5 stars$42.82+1.4%$54.57+27.4%-13.0%$4.90B$12.23B38.23135,000VRRMVerra Mobility2.7631 of 5 stars$24.14-0.9%$27.38+13.4%-8.0%$3.85B$892.73M40.231,430Positive NewsGBTGGlobal Business Travel Group2.5193 of 5 stars$6.58+0.2%$9.70+47.5%-3.0%$3.15B$2.43B-18.2619,000Positive NewsHAFNHafnia3.4796 of 5 stars$5.25flat$6.50+23.8%-32.8%$2.66B$2.63B3.095,040 Related Companies and Tools Related Companies Mondee Alternatives Booking Alternatives Expedia Group Alternatives XPO Alternatives MakeMyTrip Alternatives GATX Alternatives GXO Logistics Alternatives Verra Mobility Alternatives Global Business Travel Group Alternatives Hafnia Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRP) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotrope, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotrope With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
